PL3662080T3 - Sposób i formulacja do stabilizacji bezkomórkowych kwasów nukleinowych i komórek - Google Patents

Sposób i formulacja do stabilizacji bezkomórkowych kwasów nukleinowych i komórek

Info

Publication number
PL3662080T3
PL3662080T3 PL18745629T PL18745629T PL3662080T3 PL 3662080 T3 PL3662080 T3 PL 3662080T3 PL 18745629 T PL18745629 T PL 18745629T PL 18745629 T PL18745629 T PL 18745629T PL 3662080 T3 PL3662080 T3 PL 3662080T3
Authority
PL
Poland
Prior art keywords
stabilisation
cells
cell
composition
nucleic acids
Prior art date
Application number
PL18745629T
Other languages
English (en)
Inventor
Martin KÄMPER
Tim Kinitz
Original Assignee
Sarstedt Ag & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarstedt Ag & Co. Kg filed Critical Sarstedt Ag & Co. Kg
Publication of PL3662080T3 publication Critical patent/PL3662080T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/125—Specific component of sample, medium or buffer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
PL18745629T 2017-08-02 2018-07-30 Sposób i formulacja do stabilizacji bezkomórkowych kwasów nukleinowych i komórek PL3662080T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17184585 2017-08-02
PCT/EP2018/070633 WO2019025387A1 (de) 2017-08-02 2018-07-30 Verfahren und zusammensetzung zur stabilisierung zellfreier nukleinsäuren und zellen
EP18745629.8A EP3662080B1 (de) 2017-08-02 2018-07-30 Verfahren und zusammensetzung zur stabilisierung zellfreier nukleinsäuren und zellen

Publications (1)

Publication Number Publication Date
PL3662080T3 true PL3662080T3 (pl) 2022-04-19

Family

ID=59649475

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18745629T PL3662080T3 (pl) 2017-08-02 2018-07-30 Sposób i formulacja do stabilizacji bezkomórkowych kwasów nukleinowych i komórek

Country Status (10)

Country Link
US (1) US11591638B2 (pl)
EP (1) EP3662080B1 (pl)
JP (1) JP2020535789A (pl)
CN (1) CN110997933B (pl)
BR (1) BR112020001091A2 (pl)
CA (1) CA3067946A1 (pl)
ES (1) ES2909392T3 (pl)
PL (1) PL3662080T3 (pl)
RU (1) RU2764245C2 (pl)
WO (1) WO2019025387A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115119829B (zh) 2017-10-19 2024-07-12 斯特雷克股份有限公司 用于胞外囊泡的溶血和凝血调节以及稳定化的组合物
DE102018218739B3 (de) 2018-11-01 2020-03-19 Sarstedt Ag & Co. Kg Blutentnahmeröhre und Verfahren zur Präparation
EP4477751A1 (en) 2023-06-16 2024-12-18 QIAGEN GmbH Body fluid stabilization and processing
WO2025253002A1 (en) 2024-06-07 2025-12-11 Belgian Volition Srl Sample collection for liquid biopsy

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69033116D1 (de) * 1989-10-26 1999-06-24 Stephen T Isaacs Verfahren zur hemmung der enzymatischen herstellung von nukleinsäuren mittels isopsoralene
US5849517A (en) * 1991-05-08 1998-12-15 Streck Laboratories, Inc. Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same
FR2685696A1 (fr) * 1991-12-30 1993-07-02 Ceca Sa Procede d'obtention d'amines tertiaires methylees par reaction d'hexamethylenetetramine sur les amines ou les nitriles.
DE4338704A1 (de) * 1993-11-12 1995-05-18 Hoechst Ag Stabilisierte Oligonucleotide und deren Verwendung
JP3704982B2 (ja) * 1998-12-17 2005-10-12 ニプロ株式会社 核酸増幅用採血管
AUPR059400A0 (en) * 2000-10-06 2000-11-02 Bar-Ilan University Formaldehyde-releasing prodrugs
ATE384954T1 (de) * 2000-11-08 2008-02-15 Becton Dickinson Co Verfahren und vorrichtung zum sammeln und zum stabilisieren einer biologischen probe
EP1425294B2 (en) * 2001-08-23 2012-12-12 Veridex, LLC Analysis of circulating tumor cells, fragments, and debris
EP1516181A2 (en) * 2002-05-07 2005-03-23 Becton Dickinson and Company Container for taking samples and in particular blood samples
US6913932B2 (en) * 2002-08-23 2005-07-05 Beckman Coulter, Inc. Formaldehyde-ammonium salt complexes for the stabilization of blood cells
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
WO2005093065A1 (en) * 2004-03-16 2005-10-06 Roche Diagnostics Gmbh Improved method of isolating nucleic acids
US7700375B2 (en) * 2004-06-16 2010-04-20 Valorisation-Recherche, Lp Fluorescent labeling of specific protein targets in vitro and in vivo
DE102004056655B4 (de) * 2004-11-23 2007-03-29 Sarstedt Ag & Co. Probenröhrchen zur Aufnahme von Körperflüssigkeit, insbesondere Blut
DK2839830T3 (da) * 2005-01-14 2019-08-19 Urigen Inc Kits og sammensætninger til behandling af lidelser i de nedre urinveje
WO2007073397A1 (en) 2005-12-19 2007-06-28 Urigen, Inc. Kits and improved compositions for treating lower urinary tract discorders
AU2008224883A1 (en) * 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation and/or stabilization of a cell and/or macromolecule
CN101024645A (zh) * 2007-03-26 2007-08-29 刘长飞 甘氨酸脱醇母液回收乌洛托品和甘氨酸的方法
US9322065B2 (en) * 2007-09-17 2016-04-26 Mdxhealth Sa Methods for determining methylation of the TWIST1 gene for bladder cancer detection
US20110065108A1 (en) * 2008-02-01 2011-03-17 Siemens Healthcare Diagnostics Inc. Urine Transport Medium
FR2935704B1 (fr) * 2008-09-09 2010-08-27 Rhodia Operations Procede de fabrication d'amines
DE202010018569U1 (de) * 2009-02-18 2017-09-26 Streck Inc. Konservierung zellfreier Nukleinsäuren
KR101029154B1 (ko) * 2009-05-20 2011-04-13 한국생명공학연구원 산화아연 나노구조체 마이크로패턴 및 그 제작방법
JP5826752B2 (ja) * 2009-09-14 2015-12-02 キアジェン ゲイサーズバーグ インコーポレイテッド 細胞学用培地に固定された組織サンプルから核酸またはタンパク質を回収するための組成物および方法
CN101717112A (zh) * 2009-12-07 2010-06-02 天津大学 以dna为模板组装氧化锌纳米链的方法
BR112012016451A2 (pt) * 2010-01-04 2020-09-08 Giagen Gaithersburg, INC. métodos, composições, e kits para recuperação de ácidos nucleicos ou proteínas de amostras de tecido fixadas
US20110229879A1 (en) * 2010-03-19 2011-09-22 University Of Rochester Methods and compositions for nuclear staining
US20130137586A1 (en) * 2010-06-02 2013-05-30 Qiagen Gmbh Stabilization of nucleic acids in cell material-containing biological samples
US9023600B2 (en) * 2011-02-16 2015-05-05 The University Of Akron Highly selective pyrophosphate sensor
CN102318597B (zh) * 2011-08-19 2013-04-03 张雪云 一种液基细胞保存液组合物及其制备方法
CN103827303B (zh) * 2011-09-26 2021-10-22 普瑞阿那利提克斯有限公司 细胞外核酸的稳定化和分离
PT2814981T (pt) 2012-02-13 2017-10-03 Streck Inc Dispositivo de colheita de sangue para estabilizar adn plasmático livre de célula
EP2888363B1 (en) * 2012-08-21 2018-06-06 Qiagen GmbH Method for isolating nucleic acids from a formaldehyde releaser stabilized sample
CN104995311A (zh) * 2012-08-30 2015-10-21 外来体诊断公司 用于核酸测定的对照
JP6407248B2 (ja) * 2013-03-18 2018-10-17 キアゲン ゲーエムベーハー 細胞外核酸の安定化および単離
ES2938048T3 (es) 2013-07-24 2023-04-04 Streck Llc Composiciones y procedimientos para estabilizar las células tumorales circulantes
US9486533B2 (en) * 2013-09-27 2016-11-08 Wake Forest University Health Sciences Pharmaceutical compositions for high-capacity targeted delivery
JP6664332B2 (ja) * 2014-03-18 2020-03-13 キアゲン ゲーエムベーハー 細胞外核酸の安定化および単離
CN105087545B (zh) * 2015-08-07 2018-03-27 宁海德宝立新材料有限公司 碳酸镧分离富集核酸的方法及用途
CN105675597B (zh) * 2016-01-19 2018-06-19 济南大学 一种三维比色和光电化学纸基设备的制备及其在过氧化氢检测中的应用

Also Published As

Publication number Publication date
CA3067946A1 (en) 2019-02-07
RU2020108520A3 (pl) 2021-08-27
US20210310045A1 (en) 2021-10-07
JP2020535789A (ja) 2020-12-10
US11591638B2 (en) 2023-02-28
EP3662080A1 (de) 2020-06-10
CN110997933B (zh) 2024-01-09
BR112020001091A2 (pt) 2020-09-15
WO2019025387A1 (de) 2019-02-07
EP3662080B1 (de) 2022-01-05
RU2764245C2 (ru) 2022-01-14
ES2909392T3 (es) 2022-05-06
CN110997933A (zh) 2020-04-10
RU2020108520A (ru) 2021-08-27

Similar Documents

Publication Publication Date Title
EP3732137A4 (en) MICROBE-BASED COMPOSITION AND METHOD OF USE
IL263238A (en) Composition of probiotics and digestive enzymes and method of preparing and using the same
EP3717484A4 (en) PROCESS FOR THE PRODUCTION OF LUMATEPERON AND ITS SALT
IL254734A0 (en) Modified t cells and methods for their preparation and use
EP3277769A4 (en) Compositions and methods for the stabilization of clay-containing soils
ZA201903518B (en) Imp-producing microorganism and method of producing imp using the same
SG10201600288PA (en) Stirred Cell And Method Of Using Same
EP3231024A4 (en) Electrochemical cell and method of making the same
LT3447137T (lt) Skystas fermento preparatas ir jo gamybos būdas
EP3707300A4 (en) THERMAL INSULATION AND RELATED PROCESSES
SG11201609793TA (en) Composition and method for stabilizing and maintaining the viability of hardy microorganisms
SG11202003790PA (en) Composition and method
KR101962952B9 (ko) 자가발포형 화장료 조성물 및 그 제조 방법
ZA201806999B (en) Labeller and method of using the same
EP3399860A4 (en) NEMATODE DISPERSION COMPOSITION AND METHOD
EP3126465A4 (en) Sealing composition and method of producing the same
PL3662080T3 (pl) Sposób i formulacja do stabilizacji bezkomórkowych kwasów nukleinowych i komórek
EP3209675A4 (en) Compositions and methods for the detection of nucleic acids
EP3307873A4 (en) Hematopoietic cells and methods of using and generating the same
EP3096742A4 (en) Compositions and methods for modifying the surface of cells and methods of use
EP3239165A4 (en) Composition containing nitrogen heterocyclic hexapeptide precursor and preparation method and application thereof
EP3272751A4 (en) Crystal form of ipi-145 and preparation method thereof
EP3270985A4 (en) Polypeptide compositions and methods of using the same
EP3209262A4 (en) Memorial object and method of making the same
EP3307346A4 (en) Composition and method for inducing anti-inflammatory response